ReWalk Provides Notice of 2022 Annual Meeting of Shareholders
Annual Meeting Will be Held on July 27, 2022 MARLBOROUGH, Mass. & BERLIN & YOKNEAM ILIT, Israel--(BUSINESS WIRE)--ReWalk Robotics Ltd....
Day: June 10, 2022
NLS Pharmaceutics Announces Receipt of NASDAQ Minimum Bid Price Notification
ZURICH, SWITZERLAND / ACCESSWIRE / June 10, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP),(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
All Proposals ApprovedSAN FRANCISCO, CA / ACCESSWIRE / June 10, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company")...
Best Dentists in Denver Colorado of 2022 by TopRatedDentist.com
DENVER, CO / ACCESSWIRE / June 10, 2022 / TopRatedDentist.com has released its rankings of best dentists in Denver based...
Abivax Releases the Results of its June 9, 2022 Ordinary Annual and Extraordinary General Meeting
Shareholders approved all proposed resolutionsPARIS, FRANCE / ACCESSWIRE / June 10, 2022 / Abivax SA (Euronext Paris: FR0012333284 - ABVX),...
Better For You Wellness Raises Additional Funding to Accelerate Growth
BFYW Recently Closed First of Many Anticipated M&A TransactionsColumbus, Ohio--(Newsfile Corp. - June 10, 2022) - Better For You Wellness,...
Minutes of Implanet’s Annual General Meeting Held on June 9, 2022
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical...
Scientific Industries Integrates Important New Features into its VIVID Pill Counting Solution to Deliver Digitally Simplified Pharmacy Automation
BOHEMIA, NY / ACCESSWIRE / June 10, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a...
Jaguar Health to Participate in BIO International Convention (BIO 2022)
Jaguar seeking partnering meetings at BIO 2022 related to the company's novel plant-based FDA-approved anti-secretory agent for cancer therapy-related diarrhea...
IBEX Reports Results for the Third Quarter and the Nine Months Ended April 30, 2022
MONTRÉAL, Québec, June 10, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported...
T2 Biosystems Receives Nasdaq Extension to Comply with Bid Price Rule; Company to Transfer to Nasdaq Capital Market
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing...
Oncternal Therapeutics Presents Rationale and Plans for its Registrational Phase 3 Study Evaluating Zilovertamab in Combination with Ibrutinib at the EHA 2022 Congress
SAN DIEGO, June 10, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
ABVC BioPharma Announces Termination of Two Contracts
FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
ORYZON at EHA-2022: Iadademstat 42-month ALICE Data Demonstrate Robust Efficacy in Combination with Azacitidine in AML
81% of evaluable patients achieved an objective responseDeep responses: 64% are CR/CRi, of which 86% achieved transfusion independenceRapid and durable...
GT Biopharma Presents Preclinical Data Demonstrating Second-Generation CD19 Targeting Tri-Specific Killer Engager (TriKE®) Driving Robust NK Cell Function Against B Cell Malignancies at EHA 2022 Congress
Ongoing experiments will evaluate the functionality and efficacy of GTB-7550 in vivoFuture studies will also involve assessments of GTB-7550 TriKE...
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA
Multiplex deletion of myeloid antigens CD33 and CLL-1 in human hematopoietic stem cells demonstrates potential of next-generation HSC transplants for...
Ultragenyx to Present at Goldman Sachs Global Healthcare Conference
NOVATO, Calif., June 10, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development...
Mindset Pharma Receives Notice of Allowance for Patent Application Covering Psilocin Derivatives for the Treatment of Central Nervous System Disorders
TORONTO, June 10, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or the "Company"),...
Vincerx Pharma Presents Preclinical and Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Lymphoma at the European Hematology Association 2022 Congress
Preclinical data demonstrate VIP152 as the most selective CDK9 inhibitor compared with other CDK9 inhibitors, with the most robust MYC...
Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications
-- Results, which were previously pre-printed in bioRxiv, show Gritstone’s second-generation self-amplifying mRNA (samRNA) vaccine candidate drove broad neutralizing antibodies,...